Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

NCT00248040 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemia-Reperfusion Injury
Kidney Diseases

Interventions

DRUG: Reparixin continuous infusion
DRUG: reparixin intermittent infusion
OTHER: placebo infusion

Sponsor

Dompé Farmaceutici S.p.A